Pages that link to "Q34496604"
Jump to navigation
Jump to search
The following pages link to Long-term results in recipients of combined HLA-mismatched kidney and bone marrow transplantation without maintenance immunosuppression. (Q34496604):
Displaying 50 items.
- Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell Replacement (Q26769878) (← links)
- Deletional and regulatory mechanisms coalesce to drive transplantation tolerance through mixed chimerism (Q26801029) (← links)
- The use of novel diagnostics to individualize immunosuppression following transplantation (Q26864686) (← links)
- Hematopoietic stem and progenitor cell harvesting: technical advances and clinical utility (Q27012881) (← links)
- Immune-mediated vascular injury and dysfunction in transplant arteriosclerosis (Q28084366) (← links)
- Banking on iPSC--is it doable and is it worthwhile (Q28254023) (← links)
- Spontaneous restoration of transplantation tolerance after acute rejection (Q30657418) (← links)
- Splenocyte Infusion and Whole-Body Irradiation for Induction of Peripheral Tolerance in Porcine Lung Transplantation: Modifications of the Preconditioning Regime for Improved Clinical Feasibility (Q33443622) (← links)
- Effect of tolerance versus chronic immunosuppression protocols on the quality of life of kidney transplant recipients (Q33468225) (← links)
- Notch-Expanded Murine Hematopoietic Stem and Progenitor Cells Mitigate Death from Lethal Radiation and Convey Immune Tolerance in Mismatched Recipients (Q33722553) (← links)
- Hand transplants and the mandate for tolerance (Q35157382) (← links)
- Immunomodulatory Effects of Different Cellular Therapies of Bone Marrow Origin on Chimerism Induction and Maintenance Across MHC Barriers in a Face Allotransplantation Model (Q35879079) (← links)
- Organ-specific differences in achieving tolerance (Q35911564) (← links)
- Tolerance signatures in transplant recipients (Q35915308) (← links)
- Sequential Targeting of CD52 and TNF Allows Early Minimization Therapy in Kidney Transplantation: From a Biomarker to Targeting in a Proof-Of-Concept Trial. (Q36248860) (← links)
- Donor bone marrow cells are essential for iNKT cell-mediated Foxp3+ Treg cell expansion in a murine model of transplantation tolerance (Q36262113) (← links)
- Longitudinal studies of a B cell-derived signature of tolerance in renal transplant recipients (Q36498594) (← links)
- Use of hematopoietic cell transplants to achieve tolerance in patients with solid organ transplants (Q36727857) (← links)
- Kidney Versus Islet Allograft Survival After Induction of Mixed Chimerism With Combined Donor Bone Marrow Transplantation (Q37098988) (← links)
- Induced regulatory T cells in allograft tolerance via transient mixed chimerism (Q37109198) (← links)
- Novel surgical techniques, regenerative medicine, tissue engineering and innovative immunosuppression in kidney transplantation (Q37243068) (← links)
- Incomplete clonal deletion as prerequisite for tissue-specific minor antigen tolerization (Q37277174) (← links)
- Stable mixed chimerism and tolerance to human organ transplants (Q37337098) (← links)
- Transient mixed chimerism for allograft tolerance (Q37340107) (← links)
- Donor-Specific Regulatory T Cells Acquired from Tolerant Mice Bearing Cardiac Allograft Promote Mixed Chimerism and Prolong Intestinal Allograft Survival (Q37419992) (← links)
- Tolerance in organ transplantation: from conventional immunosuppression to extracellular vesicles. (Q38256369) (← links)
- Hematopoietic stem cell infusion/transplantation for induction of allograft tolerance (Q38309290) (← links)
- Haploidentical hematopoietic stem cell transplantation: state of art. (Q38514481) (← links)
- Immune tolerance in recipients of combined haploidentical bone marrow and kidney transplantation (Q38514510) (← links)
- Cell therapy for immunosuppression after kidney transplantation (Q38528323) (← links)
- Exploring cell-based tolerance strategies for hand and face transplantation (Q38569715) (← links)
- Post-transplantation malignancies: here today, gone tomorrow? (Q38611709) (← links)
- Islet cell transplant: Update on current clinical trials (Q38689971) (← links)
- Facilitating cells: Translation of hematopoietic chimerism to achieve clinical tolerance (Q38690514) (← links)
- A New Window into the Human Alloresponse (Q38694588) (← links)
- Mesenchymal stromal cells in renal transplantation: opportunities and challenges. (Q38725481) (← links)
- Cell therapeutic approaches to immunosuppression after clinical kidney transplantation (Q38754342) (← links)
- Immune monitoring in renal transplantation: The search for biomarkers (Q38793766) (← links)
- Face transplant: long-term follow-up and results of a prospective open study (Q38827200) (← links)
- Renal transplant immunology in the last 20 years: A revolution towards graft and patient survival improvement (Q38967258) (← links)
- Transplantation tolerance after allograft rejection (Q39023588) (← links)
- Transplant genetics and genomics (Q39175303) (← links)
- Chimerism-based tolerance in organ transplantation: preclinical and clinical studies. (Q39215677) (← links)
- Operational tolerance in kidney transplantation and associated biomarkers. (Q39267147) (← links)
- Immune monitoring as prerequisite for transplantation tolerance trials (Q39314792) (← links)
- The use of hematopoietic stem cells in autoimmune diseases (Q39777434) (← links)
- B Cell Receptor Genes Associated With Tolerance Identify a Cohort of Immunosuppressed Patients With Improved Renal Allograft Graft Function. (Q40266770) (← links)
- Erosion of Transplantation Tolerance After Infection (Q40641361) (← links)
- Onset and progression of de novo donor-specific anti-human leukocyte antigen antibodies after BK polyomavirus and preemptive immunosuppression reduction (Q40963564) (← links)
- Recent Progress in Cell Therapy in Solid Organ Transplantation (Q41444299) (← links)